Clinical Trial Information

Protocol: ECOG – EA2186

SCHEMA EA2186

Please Note: Below is a brief description of eligibility, please contact GHCI Research Department to discuss full eligibility requirements.

Eligibility:

1. Newly diagnosed untreated metastatic adenocarcinoma of the pancreas. However, previous surgery, adjuvant chemotherapy and/or radiation therapy will be allowed, provided radiation therapy is completed at least 2 weeks prior to registration and adjuvant therapy was administered more than 6 months prior to registration. Patients with the following histology are excluded: Acinar cell; Adenosquamous carcinoma.
2. Patient must be ≥ 70 years of age.
3. Patient must have an ECOG Performance status 0-2.
4. Patient must have measurable disease.